Groundbreaking Study Links Anxiety Disorders to Brain Receptor and Testosterone

Research reveals testosterone administration can rectify deficiencies caused by TACR3 inactivity, offering new therapeutic possibilities for anxiety treatment.

• Groundbreaking study reveals a significant link between anxiety disorders and a brain receptor known as TACR3, as well as testosterone.
• Male rodents with high anxiety levels had notably lower levels of TACR3 in their hippocampus, a brain region associated with learning and memory processes.
• Deficiencies stemming from TACR3 inactivity could be efficiently rectified through testosterone administration, offering potential new approaches to treat anxiety associated with testosterone deficiency.
• The research employed innovative tools like FORTIS and cross-correlation in multi-electrode arrays, advancing understanding of synaptic plasticity and its role in anxiety.
• Findings open new therapeutic possibilities for treating anxiety disorders, especially in individuals with hypogonadism, a condition characterized by reduced sexual function.

3 Articles

ScienceDaily Neuroscience News The Jerusalem Post